Notably, more recent guidelines suggest using an ALT test alone to screen for nonalcoholic fatty liver disease,26 suggesting clinicians who ordered separate AST and ALT tests could have been even more parsimonious. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.